EUVIMEDEUVIMED entdecken
Crossref

In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L

Lin Wei, Yuqi Wu, Shuai Li, Jun Weng, Miaomiao Geng, Meng Mei, Zigong Wei iD

FEMS Microbiology Letters · 2025

DOI: 10.1093/femsle/fnaf008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Letters, 2025. Verfasst von Lin Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, College of Life Sciences, H…. Hauptthemen laut MEDLINE: Monkeypox virus, Antiviral Agents, Viral Proteins, Protease Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of China, State Key Laboratory of Biocatalysis and Enzyme Engineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monkeypox is a zoonotic viral disease caused by the monkeypox virus, a member of the genus Orthopoxvirus within the family Poxviridae, which also includes the variola virus. On 14 August 2024, WHO Director-General declared monkeypox outbreak a public health emergency of international concern. Similar to variola virus core protease K7L, I7L could be identified as a promising target to fight against monkeypox virus. Our work provides a solid foundation as well as specific molecular tools (protease production methods, assay design, inhibitor design) that can now be used to probe the function of I7L in vitro. Notably, in this work, various reported covalent lead compounds for COVID-19 proteases were screened and A68, shikonin, and myricetin were identified as exhibiting high inhibitory activity against I7L. This work not only sheds light on effective inhibitors for the monkeypox virus core protease but also contributes to the broader search for antiviral agents targeting this enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monkeypox virusAntiviral AgentsViral ProteinsProtease InhibitorsViral ProteasesHumansSARS-CoV-2

Stichwörter der Autor:innen

I7Lcovalent inhibitormonkeypox virus (MPXV)myricetinshikonin

Substanzen

Antiviral AgentsViral ProteinsProtease InhibitorsViral Proteases

Autor:innen und Institutionen

  • State Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, College of Life Sciences, Hubei University, Wuhan 430062, China.
  • Hubei Jiangxia Laboratory, Wuhan 430207, China.
  • Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
  • National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Life Sciences, Hubei University…

ORCID-Profile: Zigong Wei

Förderung

  • Natural Science Foundation of China
  • State Key Laboratory of Biocatalysis and Enzyme Engineering

Zitieren

APA

Wei, L., Wu, Y., Li, S., Weng, J., Geng, M., Mei, M., & Wei, Z. (2025). In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L. FEMS Microbiology Letters. https://doi.org/10.1093/femsle/fnaf008

Vancouver

Wei L, Wu Y, Li S, Weng J, Geng M, Mei M, et al. In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L. FEMS Microbiology Letters. 2025. doi:10.1093/femsle/fnaf008

BibTeX
@article{Wei2025,
  author = {Wei, Lin and Wu, Yuqi and Li, Shuai and Weng, Jun and Geng, Miaomiao and Mei, Meng and Wei, Zigong},
  title = {In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L},
  journal = {FEMS Microbiology Letters},
  year = {2025},
  doi = {10.1093/femsle/fnaf008}
}
Kostenlos starten →